Lsv Asset Management Exelixis, Inc. Transaction History

Lsv Asset Management

$41.7 Billion
Q1 2025

A detailed history of Lsv Asset Management transactions in Exelixis, Inc. stock. As of the latest transaction made, Lsv Asset Management holds 8,161,338 shares of EXEL stock, worth $308 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

8,161,338

Previous 8,169,847 0.1%

Holding current value

$308 Million

Previous $272 Million 10.76%

% of portfolio

0.72%

Previous 0.63%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	SELL	$32.38 - $39.16 $275,521 - $333,212	-8,509 Reduced 0.1%	8,161,338 $301 Million
Q4 2024 Feb 13, 2025	BUY	$25.39 - $36.46 $1.71 Million - $2.46 Million	67,470 Added 0.83%	8,169,847 $272 Million
Q3 2024 Nov 12, 2024	BUY	$21.96 - $27.6 $51.4 Million - $64.5 Million	2,338,649 Added 40.58%	8,102,377 $210 Million
Q2 2024 Aug 06, 2024	BUY	$20.34 - $23.73 $60.8 Million - $70.9 Million	2,989,021 Added 107.72%	5,763,728 $130 Million
Q1 2024 May 06, 2024	BUY	$20.17 - $23.93 $52.8 Million - $62.6 Million	2,616,278 Added 1651.39%	2,774,707 $65.8 Million
Q4 2023 Feb 06, 2024	SELL	$19.25 - $24.13 $16.9 Million - $21.2 Million	-879,211 Reduced 84.73%	158,429 $3.8 Million
Q3 2023 Nov 03, 2023	SELL	$19.04 - $22.74 $4.38 Million - $5.23 Million	-229,835 Reduced 18.13%	1,037,640 $22.7 Million
Q2 2023 Aug 02, 2023	SELL	$18.17 - $20.48 $15.2 Million - $17.2 Million	-838,909 Reduced 39.83%	1,267,475 $24.2 Million
Q1 2023 May 02, 2023	SELL	$16.3 - $19.41 $6.62 Million - $7.89 Million	-406,299 Reduced 16.17%	2,106,384 $40.9 Million
Q4 2022 Feb 08, 2023	BUY	$14.96 - $17.39 $7.14 Million - $8.31 Million	477,585 Added 23.47%	2,512,683 $40.3 Million
Q3 2022 Nov 07, 2022	BUY	$15.68 - $22.27 $3.78 Million - $5.37 Million	241,137 Added 13.44%	2,035,098 $31.9 Million
Q2 2022 Aug 10, 2022	BUY	$17.44 - $23.16 $21.4 Million - $28.4 Million	1,226,172 Added 215.96%	1,793,961 $37.4 Million
Q1 2022 May 12, 2022	BUY	$17.03 - $22.67 $9.67 Million - $12.9 Million	567,789 New	567,789 $12.9 Million
Q4 2020 Feb 08, 2021	SELL	$18.39 - $24.8 $1.4 Million - $1.89 Million	-76,200 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$15.15 - $18.89 $1.15 Million - $1.44 Million	76,200 New	76,200 $1.34 Million

Others Institutions Holding EXEL

# of Institutions

650

Shares Held

256M

Call Options Held

1.67M

Put Options Held

733K

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $12.1B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.

Account

Lsv Asset Management Exelixis, Inc. Transaction History